Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Investor Growth Capital
Mandate

Vinge advises Investor Growth Capital

January 30, 2009

Vinge has advised Investor Growth Capital in connection with its investment in Synosia Therapeutics. Synosia Therapeutics is a company which develops and intends to commercialise innovative and clinically differentiated products for unfulfilled medical requirements within psychiatry and neurology.
 
Vinge’s team consisted of responsible partner Johan Winnerblad together with associate Karl Svantema.

Related

Vinge advises Chieftain Capital Management in connection with the investment in Koenigsegg Automotive

Vinge has advised Chieftain Capital Management, Inc. (”Chieftain”), a New York based family office, in its investment in the Swedish megacar manufacturer Koenigsegg Automotive AB (“Koenigsegg”).
October 08, 2024

Vinge advises iBinder Group in connection with the acquisition of Avima AB

Avima AB is a Swedish specialist in project and information management, with expertise in complex projects within construction, real estate and infrastructure.
October 07, 2024

Vinge advises Axcel in connection with the launch of Accru Partners, a new group within accounting, tax, audit and advisory services

 Vinge has advised the Nordic private equity firm Axcel in connection with its establishment of Accru Partners, a new group of 22 independent firms in Sweden within accounting, tax, audit and other advisory services.
October 04, 2024